RAINBOW CHILDRENS MEDICARE
|
RAINBOW CHILDRENS MEDICARE Last 5 Year Financial Ratios History
[Consolidated]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 21.38 | 20.77 | 14.70 | 9.10 | 12.68 |
| CEPS(Rs) | 32.55 | 29.82 | 23.60 | 12.53 | 13.84 |
| DPS(Rs) | 3.00 | 3.00 | 2.00 | - | 2.00 |
| Book NAV/Share(Rs) | 123.08 | 104.42 | 62.93 | 99.05 | 89.73 |
| Tax Rate(%) | 25.96 | 24.63 | 25.98 | 28.96 | 40.72 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 33.34 | 34.05 | 31.61 | 25.40 | 27.90 |
| EBIT Margin(%) | 27.55 | 28.99 | 25.01 | 15.70 | 19.69 |
| Pre Tax Margin(%) | 22.73 | 24.01 | 19.24 | 8.57 | 12.98 |
| PAT Margin (%) | 16.83 | 18.10 | 14.24 | 6.09 | 7.69 |
| Cash Profit Margin (%) | 25.47 | 25.79 | 22.79 | 17.37 | 17.34 |
| Performance Ratios | |||||
| ROA(%) | 11.23 | 14.02 | 11.74 | 3.64 | 6.68 |
| ROE(%) | 18.91 | 25.72 | 27.00 | 9.54 | 13.85 |
| ROCE(%) | 30.82 | 39.96 | 42.92 | 21.42 | 30.56 |
| Asset Turnover(x) | 0.67 | 0.77 | 0.82 | 0.60 | 0.87 |
| Sales/Fixed Asset(x) | 0.84 | 0.95 | 0.90 | 0.70 | 1.12 |
| Working Capital/Sales(x) | 2.75 | 3.46 | 5.90 | 8.66 | 9.90 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 1.19 | 1.06 | 1.11 | 1.42 | 0.89 |
| Receivable days | 17.12 | 14.24 | 15.81 | 24.69 | 18.40 |
| Inventory Days | 6.01 | 5.22 | 4.67 | 7.32 | 5.83 |
| Payable days | 177.11 | 165.20 | 110.68 | 197.76 | 161.38 |
| Valuation Parameters | |||||
| PER(x) | 60.71 | 35.16 | - | - | - |
| PCE(x) | 39.88 | 24.49 | - | - | - |
| Price/Book(x) | 10.55 | 6.99 | - | - | - |
| Yield(%) | 0.23 | 0.41 | - | - | - |
| EV/Net Sales(x) | 10.15 | 6.28 | -0.04 | 0.01 | 0.02 |
| EV/Core EBITDA(x) | 28.04 | 17.11 | -0.12 | 0.03 | 0.06 |
| EV/EBIT(x) | 36.84 | 21.65 | -0.17 | 0.06 | 0.09 |
| EV/CE(x) | 10.46 | 6.95 | -0.03 | 0.01 | 0.01 |
| M Cap / Sales | 10.16 | 6.32 | - | - | - |
| Growth Ratio | |||||
| Net Sales Growth(%) | 10.51 | 20.52 | 49.80 | -9.64 | 32.54 |
| Core EBITDA Growth(%) | 9.06 | 31.72 | 86.30 | -16.88 | 75.52 |
| EBIT Growth(%) | 5.05 | 39.69 | 138.58 | -27.93 | 69.99 |
| PAT Growth(%) | 2.78 | 53.15 | 250.47 | -28.50 | -4.47 |
| EPS Growth(%) | 2.93 | 41.30 | 61.48 | -28.19 | -3.41 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | - | - | 0.07 | 0.10 | 0.14 |
| Current Ratio(x) | 4.16 | 3.44 | 2.32 | 1.61 | 1.42 |
| Quick Ratio(x) | 4.00 | 3.31 | 2.20 | 1.53 | 1.33 |
| Interest Cover(x) | 5.71 | 5.83 | 4.34 | 2.20 | 2.93 |
| Total Debt/Mcap(x) | - | - | - | - | - |
Compare Financial Ratios of peers of RAINBOW CHILDRENS MEDICARE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| RAINBOW CHILDRENS MEDICARE | ₹15,979.6 Cr | -1.7% | 12.7% | 49.7% | Stock Analytics | |
| APOLLO HOSPITALS ENTERPRISE | ₹96,963.3 Cr | -1.7% | -3.4% | 25.1% | Stock Analytics | |
| MAX HEALTHCARE INSTITUTE | ₹96,207.0 Cr | -1.3% | 4.1% | 62% | Stock Analytics | |
| FORTIS HEALTHCARE | ₹51,378.7 Cr | 9.6% | 11.9% | 81.5% | Stock Analytics | |
| GLOBAL HEALTH | ₹28,800.4 Cr | 3.6% | 2.4% | 22.3% | Stock Analytics | |
| NARAYANA HRUDAYALAYA | ₹25,729.0 Cr | 0% | -1.2% | 10.4% | Stock Analytics | |
RAINBOW CHILDRENS MEDICARE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| RAINBOW CHILDRENS MEDICARE | -1.7% |
12.7% |
49.7% |
| SENSEX | -1.9% |
-5% |
17.5% |
You may also like the below Video Courses
